Amylin Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
March 08 2007 - 4:05PM
PR Newswire (US)
SAN DIEGO, March 8 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Cowen
and Company 27th Annual Health Care Conference on Wednesday, March
14, 2007 at 10:15 a.m. ET in Boston. Daniel M. Bradbury, President
and Chief Executive Officer of Amylin Pharmaceuticals, will be
providing a corporate overview. The live presentation and breakout
session will be webcast, and a recording will be made available
following the event. The webcast and recording will be accessible
through Amylin's corporate website, located at
http://www.amylin.com/. To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is located in San Diego, California
with over 1,600 employees nationwide. For more information about
Amylin visit http://www.amylin.com/. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director,
Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024